“Adam Goldstein, MD, MPH, and Ilona Jaspers, PhD, share their responses to the terms of e-cigarette manufacturer Juul Labs’ settlement in a lawsuit from North Carolina’s attorney general. Read their opinions on what this means for the state and the future of youth vaping.” (From UNC Health Newsroom). Click here to read the whole article.
David Peden, MD, is excitedly set to serve as the Editor-in-Chief of JACI: Global. Read more here!
The goal of this grant is to characterize a new mouse model of severe asthma which exhibits extreme sensitivity to allergen-induced allergic inflammation and steroid resistance. Drs. Kelada and Moran will characterize which immune pathways underlie this strain’s susceptibility to allergic inflammation and also identify which genes confer this susceptibility. The results of their work … Read more
David Peden, MD, is the principal investigator of the University of North Carolina site for the “Systemic Allergy Reactions to SARS-CoV-2 Vaccination” clinical study. Read more here.
A new video is available here about the importance of double-masking by Emily Sickbert-Bennett, PhD, and Phillip Clapp, PhD.
Collaborative research between CEMALB and EPA investigators shows that double masking can provide additional protection for the wearer. However, improving fit with the outer mask is key. Read more here!
Rebuli and team’s “Electronic-cigarette use alters nasal mucosal immune response to live-attenuated influenza virus. A clinical trial.” received recognition as Extramural Paper of the Month in NIEHS’ Environmental Factor. Click here to read more!
“Starting in February 2021, a new collaborative initiative between the UNC Institute for the Environment, the Curriculum in Toxicology and Environmental Medicine in the UNC School of Medicine, and the Department of Biological and Biomedical Sciences at North Carolina Central University (NCCU), will provide research opportunities for diverse undergraduates through a new program called the … Read more
Dr. Moran’s proposal titled Role of the Indoor Exposome in Peanut Allergy Development received new funding this week.